Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122

Affiliations

¹ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain aceriell@clinic.ub.es.
² Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
³ Diabetology, Careggi Hospital, University of Florence, Florence, Italy.

Comment

Antonio Ceriello et al. Diabetes Care. 2016 Nov.

. 2016 Nov;39(11):e195.

doi: 10.2337/dc16-1332.

¹ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain aceriell@clinic.ub.es.
² Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
³ Diabetology, Careggi Hospital, University of Florence, Florence, Italy.

No abstract available

Comment in

Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
Ferrannini E, Mark M, Mayoux E. Ferrannini E, et al. Diabetes Care. 2016 Nov;39(11):e196-e197. doi: 10.2337/dci16-0027. Diabetes Care. 2016. PMID: 27926896 No abstract available.

Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis.
Mudaliar S, Alloju S, Henry RR. Mudaliar S, et al. Diabetes Care. 2016 Jul;39(7):1115-22. doi: 10.2337/dc16-0542. Diabetes Care. 2016. PMID: 27289124
CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.
Ferrannini E, Mark M, Mayoux E. Ferrannini E, et al. Diabetes Care. 2016 Jul;39(7):1108-14. doi: 10.2337/dc16-0330. Diabetes Care. 2016. PMID: 27289126